No Data
No Data
Will Relmada Therapeutics (NASDAQ:RLMD) Spend Its Cash Wisely?
Analysts Offer Insights on Healthcare Companies: Relmada Therapeutics (RLMD) and Neumora Therapeutics, Inc. (NMRA)
Earnings Call Summary | Relmada Therapeutics(RLMD.US) Q2 2024 Earnings Conference
Optimistic Outlook for Relmada Therapeutics: Strategic Trial Enhancements and Solid Financial Position
Express News | Relmada Therapeutics Shares Are Trading Lower. The Company Reported Q2 Financial Results
Express News | Relmada Therapeutics Inc : Jefferies Cuts Target Price to $3.50 From $5.50
BooBooG : cannot